2020-14875. Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at https://www.reginfo.gov/​public/​do/​PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.

    Table 1—List of Information Collections Approved by OMB

    Title of collectionOMB control No.Date approval expires
    Formal Meetings Between the Food and Drug Administration and Sponsors and Applicants of Prescription Drug User Fee Act Products0910-04295/31/2023
    Special Protocol Assessments0910-04705/31/2023
    Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements0910-06065/31/2023
    Tracking Network for PETNet, LivestockNet, and SampleNet0910-06805/31/2023
    Center for Tobacco Products, Food and Drug Administration Funded Trainee/Scholar Survey0910-08875/31/2023
    Importer's Entry Notice0910-00466/30/2023
    Premarket Notification Submission 510(k), Subpart E0910-01206/30/2023
    Medical Devices; Pediatric Uses of Devices; Requirement for Submission of Information on Pediatric Subpopulations0910-07486/30/2023
    Controlled Correspondence Related to Generic Drug Development0910-07976/30/2023
    Certification of Identity for Freedom of Information Act and Privacy Act Requests0910-08326/30/2023
    FDA Advisory Committee Membership Nominations0910-08336/30/2023
    Start Signature

    Dated: July 6, 2020.

    Lowell J. Schiller,

    Principal Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2020-14875 Filed 7-9-20; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
07/10/2020
Department:
Health and Human Services Department
Agency:
Food and Drug Administration
EntryType:
Notice
Action:
Notice.
Document Number:
2020-14875
Pages:
41591-41591 (1 pages)
Docket Numbers:
Docket Nos. FDA-2018-N-2434, FDA-2016-N-3535, FDA-2013-N-1619, FDA-2016-N-0736, FDA-2019-N-3885, FDA-2013-N-1423, FDA-2013-N-0804, FDA-2016-N-3995, FDA-2018-D-1592, FDA-2016-N-2066, and FDA-2017-N-0366
SectionNoes:
PDF File:
2020-14875.pdf